Generation Bio Co reports results for the quarter ended in March - Earnings Summary

Generation Bio

10/05/2022 13:00

* Generation Bio Co  GBIO.OQ  reported a quarterly adjusted
loss
of 61 cents​​ per share for the quarter ended in March. The mean
expectation of six analysts for the quarter was for a loss of 52
cents per share.
    * Reported revenue was zero​;  analysts expected $1.50
million. 
    * Generation Bio Co's reported EPS for the quarter was a
loss
of 61 cents​.
    * The mean earnings estimate of analysts had risen by
about 6.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Generation Bio Co shares had fallen by 25.9% this
quarter and
lost 23.2% so far this year.
    * The company reported a quarterly loss of $35 million.
    * Wall Street's median 12-month price target for Generation
Bio Co
is $25.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 10 at 12:00 p.m.  ​All
figures in US dollars unless otherwise stated